14 news items
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
15 Jun 24
a complaint against Regeneron under the False Claims Act. The lawsuit accuses the Company of failing to report millions of dollars in discounts
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
13 Jun 24
of Justice ("DOJ") issued a press release announcing that it had filed a complaint against Regeneron under the False Claims Act. The lawsuit accuses
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
5 Jun 24
of Justice ("DOJ") issued a press release announcing that it had filed a complaint against Regeneron under the False Claims Act. The lawsuit accuses
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
3 Jun 24
against Regeneron under the False Claims Act. The lawsuit accuses the Company of failing to report millions of dollars in discounts provided to drug
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
30 May 24
a complaint against Regeneron under the False Claims Act. The lawsuit accuses the Company of failing to report millions of dollars in discounts
hieknyybfc7fi81hhvw1f1blg200kn4w55f1mhdog
REGN
28 May 24
("DOJ") issued a press release announcing that it had filed a complaint against Regeneron under the False Claims Act. The lawsuit accuses the Company
8d87cul5nwwsxr556kviy2h1gc0buzs66uc
REGN
22 May 24
("DOJ") issued a press release announcing that it had filed a complaint against Regeneron under the False Claims Act. The lawsuit accuses
5c405obnx8e6m504zqwslb3zozqwpi5 ilo
REGN
20 May 24
("DOJ") issued a press release announcing that it had filed a complaint against Regeneron under the False Claims Act. The lawsuit accuses the Company
4r6r3hqeuyups59ut9n5lp1l6rfx83cespalx0cguurf73kr9c9qs1j
DV
JBL
REGN
19 May 24
. (NASDAQ:REGN) Regeneron is the subject of a DOJ lawsuit
mvwgn8 v3npmgtzndnycaqjslaz1gb
REGN
16 May 24
the False Claims Act. The lawsuit accuses the Company of failing to report millions of dollars in discounts provided to drug distributors. As a result
bd8hd6xr11s9m4a49pof6iribjvrqchwzc6x1cghl4pvrb1imoyejfzd
REGN
18 Apr 24
") issued a press release announcing its complaint filed against Regeneron under the False Claims Act. The lawsuit accuses the Company of failing
a8zdsx327khf8c8k8w07nkgro 5297bml
REGN
17 Apr 24
is the subject of a DOJ lawsuit filed on April 10, 2024. The lawsuit accuses Regeneron of failing to report millions of dollars in discounts given
q2wb62c4nod4slrms1f4cxvdinlbj9vs9n3hz lko2xqtzygxuo
REGN
11 Apr 24
the average sales price of Eylea, a move that significantly impacted Medicare expenses.
According to the lawsuit, Reuters highlighted that Regeneron
wquoxn6mnyltsg5 twl
REGN
11 Apr 24
of a DOJ lawsuit filed on April 10, 2024. The lawsuit alleges that the Company failed to disclose millions of dollars in price concessions given
- Prev
- 1
- Next